Skip to main content
. 2021 May 24;61(7):442–451. doi: 10.2176/nmc.oa.2021-0017

Table 2. Blood tests at enrollment and 6 months follow-up.

Variables Statin (n = 93) Control (n = 116) P value
Enrollment
LDL, mg/dL 121 ± 28.6 118 ± 25.3 0.31
HDL, mg/dL 62.1 ± 15.7 62.3 ± 15.8 0.85
TG, mg/dL 138.4 ± 94.1 137.2 ± 78.2 0.92
CRP, mg/dL 0.11 ± 0.21 0.10 ± 0.17 0.86
GOT, U/L 21.8 ± 6.4 23.5 ± 7.9 0.29
GPT, U/L 21.8 ± 12.8 20.8 ± 11.7 0.54
HbA1C, % 5.63 ± 0.56 5.60 ± 0.46 0.75
6 months
LDL, mg/dL 72.8 ± 20.0 118.9 ± 26.5 <0.001
HDL, mg/dL 64.0 ± 15.1 61.6 ± 16.4 0.32
TG, mg/dL 111.3 ± 66.8 146.6 ± 99.1 <0.01
CRP, mg/dL 0.09 ± 0.18 0.11 ± 0.21 0.53
GOT, U/L 23.8 ± 6.4 23.4 ± 8.9 0.76
GPT, U/L 24.9 ± 12.8 22.5 ± 15.4 0.24
HbA1C, % 5.86 ± 0.64 5.62 ± 0.44 <0.01

CRP: C-reactive protein, GOT: glutamic-oxaloacetic transaminase, GPT: glutamic pyruvic transaminase, HbA1C: hemoglobin A1c, HDL: high-density lipoprotein, LDL: low-density lipoprotein, TG: triglyceride.